Correlation Between Aptose Biosciences and Theratechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and Theratechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and Theratechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptose Biosciences and Theratechnologies, you can compare the effects of market volatilities on Aptose Biosciences and Theratechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of Theratechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and Theratechnologies.

Diversification Opportunities for Aptose Biosciences and Theratechnologies

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Aptose and Theratechnologies is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and Theratechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theratechnologies and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with Theratechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theratechnologies has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and Theratechnologies go up and down completely randomly.

Pair Corralation between Aptose Biosciences and Theratechnologies

Assuming the 90 days trading horizon Aptose Biosciences is expected to under-perform the Theratechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Aptose Biosciences is 1.12 times less risky than Theratechnologies. The stock trades about -0.15 of its potential returns per unit of risk. The Theratechnologies is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  520.00  in Theratechnologies on August 29, 2024 and sell it today you would lose (346.00) from holding Theratechnologies or give up 66.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.47%
ValuesDaily Returns

Aptose Biosciences  vs.  Theratechnologies

 Performance 
       Timeline  
Aptose Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Theratechnologies 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Theratechnologies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Theratechnologies is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Aptose Biosciences and Theratechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aptose Biosciences and Theratechnologies

The main advantage of trading using opposite Aptose Biosciences and Theratechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, Theratechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will offset losses from the drop in Theratechnologies' long position.
The idea behind Aptose Biosciences and Theratechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum